Appropriateness and safety of using cannabinoid and psychedelic medicines as treatments for psychiatric disorders (2023) Editorial 12 May Written By Simon Ruffell Grace Blest-Hopley, Ben Amit, Aisling O'Neill, & Simon Ruffell Medical cannabis and psychedelics have shown promising results in treating various psychiatric disorders, but the lack of robust evidence remains a significant challenge. In this edition, we share intriguing insights into the specific applications of certain substances. Read full paper Simon Ruffell
Appropriateness and safety of using cannabinoid and psychedelic medicines as treatments for psychiatric disorders (2023) Editorial 12 May Written By Simon Ruffell Grace Blest-Hopley, Ben Amit, Aisling O'Neill, & Simon Ruffell Medical cannabis and psychedelics have shown promising results in treating various psychiatric disorders, but the lack of robust evidence remains a significant challenge. In this edition, we share intriguing insights into the specific applications of certain substances. Read full paper Simon Ruffell